MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis
If these symptoms persist, talk to a healthcare provider
Rat chow (standard diet for laboratory animals - NUVILAB CR-1 , Brazil) and filtered water were available ad libitum
A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
B12 has also been shown to bind with neurotransmitters such as dopamine and serotonin